You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gastroenteropancreatic Neuroendocrine Tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastroenteropancreatic Neuroendocrine Tumours

Recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included
  • Milano, Italy
    Irccs San Raffaele
Nov 24, 2023

Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)

Not yet recruiting
  • Advanced Gastroenteropancreatic Neuroendocrine Tumor
  • (no location specified)
Oct 16, 2023

Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Trial in Cleveland (TQ Formula (black

Not yet recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Gastroenteropancreatic Neuroendocrine Neoplasm
  • TQ Formula (black seed oil capsules)
  • +2 more
  • Cleveland, Ohio
    University hospitals Seidman Cancer Center, Case Comprehensive C
Aug 12, 2022

Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (Lutetium (177Lu) Oxodotreotide Injection;long-acting Octreotide,

Not yet recruiting
  • Advanced Gastroenteropancreatic Neuroendocrine Tumor
  • Lutetium (177Lu) Oxodotreotide Injection；long-acting Octreotide
  • long-acting Octreotide.
  • (no location specified)
May 22, 2023

Lutathera® in Somatostatin Receptor Positive

Recruiting
  • Somatostatin Receptor-positive GEP-NET
  • Lutathera
  • Seongnam Si, Gyeonggi Do, Korea, Republic of
  • +4 more
Jun 29, 2022

GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

Recruiting
  • GEP-NET
  • +6 more
  • Duarte, California
  • +3 more
Jul 28, 2022

Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

Not yet recruiting
  • Digestive System Neuroendocrine Tumor G1
  • +5 more
  • Tumor Debulking
  • +5 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 23, 2023

Neuroendocrine Tumors, Carcinoid Tumor, Pulmonary Carcinoid Tumor Trial in Vancouver (177Lu-DOTATOC)

Not yet recruiting
  • Neuroendocrine Tumors
  • +6 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Aug 19, 2022

Nutrition in Gastroenteropancreatic Neuroendocrine Tumor

Active, not recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
    • El Palmar, Murcia, Spain
    • +15 more
    Feb 16, 2022

    Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))

    Suspended
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Stanford, California
      Stanford Cancer Institute Palo Alto
    Sep 21, 2022

    Gastroenteropancreatic Neuroendocrine Tumor Trial in Belgium, Netherlands (Somatostatin analog)

    Not yet recruiting
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Somatostatin analog
    • Brasschaat, Antwerp, Belgium
    • +19 more
    Jan 31, 2023

    Assay asBiomarker for Gastroenteropancreatic and Lung

    Completed
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Lung Neuroendocrine Neoplasm
    • NETest
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Aug 3, 2021

    Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,

    Recruiting
    • Advanced Solid Tumors
    • +11 more
    • Boston, Massachusetts
    • +4 more
    Dec 12, 2022

    Gastroenteropancreatic Neuroendocrine Tumor Trial in China (Lanreotide autogel)

    Completed
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Lanreotide autogel
    • Sichuan, Chengdu, China
    • +13 more
    Jan 16, 2023

    Effectiveness and Outcomes Associated With Lutathera Treatment

    Active, not recruiting
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Alessandria, Italy
    • +17 more
    May 4, 2022

    Neuroendocrine Tumor, Gastroenteropancreatic Trial in Milano (Surgery)

    Active, not recruiting
    • Neuroendocrine Tumor
    • Gastroenteropancreatic
    • Surgery
    • Milano, Italy
      San Raffaele Hospital IRCCS
    May 5, 2022

    Neuroendocrine Tumors - Patient Reported Outcomes

    Enrolling by invitation
    • Neuroendocrine Tumors
    • +3 more
      • Gainesville, Florida
      • +13 more
      Jul 7, 2022

      Metastatic Well Differentiated Neuroendocrine Tumor, Neuroendocrine Tumors Trial in Milano (Cabozantinib, Lanreotide)

      Recruiting
      • Metastatic Well Differentiated Neuroendocrine Neoplasm
      • Neuroendocrine Tumors
      • Milano, Italy
        Fondazione IRCCS Istituto Nazionale dei Tumori
      Sep 3, 2021

      Neuroendocrine Tumors Trial in Beijing (Lutetium[177Lu] Oxodotreotide Injection)

      Not yet recruiting
      • Neuroendocrine Tumors
      • Lutetium[177Lu] Oxodotreotide Injection
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      May 30, 2023

      Metastatic Digestive System Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in United States (Lutetium Lu 177

      Recruiting
      • Metastatic Digestive System Neuroendocrine Neoplasm
      • Metastatic Neuroendocrine Tumor
      • Phoenix, Arizona
      • +10 more
      Aug 23, 2022

      Neuroendocrine Tumor, Liver Metastases, Neuroendocrine Gastroenteropancreatic Tumour Trial in France (Positron emission

      Recruiting
      • Neuroendocrine Tumor
      • +2 more
      • Positron emission tomography computed tomography (PET/CT) with Intra-hepatic (IAH) injection
      • +3 more
      • Bordeaux, France
      • +3 more
      Nov 18, 2021

      Gastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic System Trial in Germany (Pasireotide LAR

      Completed
      • Gastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic System
      • Pasireotide LAR followed by Pasireotide LAR + Everolimus
      • Everolimus followed by Pasireotide LAR + Everolimus
      • Bad Berka, Germany
      • +3 more
      Dec 17, 2020

      Neuroendocrine Tumors, Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors Trial in New York (177Lu-DOTATATE)

      Recruiting
      • Neuroendocrine Tumors
      • Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 19, 2023

      Gastroenteropancreatic Neuroendocrine Tumors, Pheochromocytoma, Paraganglioma Trial in Worldwide (Lutetium [177Lu]

      Recruiting
      • Gastroenteropancreatic Neuroendocrine Tumors
      • +2 more
      • Lutetium [177Lu] oxodotreotide/dotatate
      • Iowa City, Iowa
      • +16 more
      Apr 6, 2022

      Neuroendocrine Tumors Trial in Toronto (F18-FDG)

      Recruiting
      • Neuroendocrine Tumors
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      May 20, 2022